| Identification | More | [Name]
1-Piperonylpiperazine | [CAS]
32231-06-4 | [Synonyms]
1-[(1,3-BENZODIOXOL-5-YL)METHYL]PIPERAZINE
1-(3,4-METHYLENDIOXYBENZYL)PIPERAZINE
1-(3,4-METHYLENEDIOXYBENZYL)PIPERAZINE
1-BENZO[1,3]DIOXOL-5-YLMETHYL-PIPERAZINE
1-PIPERONYLPIPERAZINE
3,4-METHYLENEDIOXY-1-(N-PIPERAZINYL)-BENZENE
AKOS B020126
AKOS BBS-00006443
LABOTEST-BB LT00053351
N-PIPERONYL PIPERAZINE
PIPERONYL PIPERAZINE
1-(3,4-methylenedioxybenzyl)-piperazin
3,4-Methylenedioxybenzyl piperazine
L-Piperonylpiperazine
1-PIPERONYLPIPERAZINE 98%
1-Piperonylpiperazine ,97%
5-(Piperazinomethyl)-1,3-benzodioxole | [EINECS(EC#)]
250-968-5 | [Molecular Formula]
C12H16N2O2 | [MDL Number]
MFCD00005834 | [Molecular Weight]
220.27 | [MOL File]
32231-06-4.mol |
| Chemical Properties | Back Directory | [Appearance]
white to yellow or yellow-brownish cryst. solid | [Melting point ]
36-40 °C (lit.) | [Boiling point ]
147-149 °C/2 mmHg (lit.) | [density ]
1.1115 (rough estimate) | [refractive index ]
1.5460 (estimate) | [Fp ]
>230 °F
| [Water Solubility ]
Slightly soluble in water | [form ]
Crystalline Solid | [pka]
9.14±0.10(Predicted) | [color ]
White to yellow or yellow-brownish | [BRN ]
885038 | [CAS DataBase Reference]
32231-06-4(CAS DataBase Reference) |
| Safety Data | Back Directory | [Hazard Codes ]
Xi | [Risk Statements ]
R36/37/38:Irritating to eyes, respiratory system and skin . | [Safety Statements ]
S26:In case of contact with eyes, rinse immediately with plenty of water and seek medical advice .
S37/39:Wear suitable gloves and eye/face protection . | [RIDADR ]
3259 | [WGK Germany ]
3
| [RTECS ]
TM1550000
| [Hazard Note ]
Irritant | [HazardClass ]
8 | [PackingGroup ]
II | [HS Code ]
29349990 |
| Hazard Information | Back Directory | [Chemical Properties]
white to yellow or yellow-brownish cryst. solid | [Uses]
1-Piperonylpiperazine (cas# 32231-06-4) is a compound useful in organic synthesis. | [General Description]
The effect of 1-piperonylpiperazine on 3,4-methylenedioxymethamphetamine (MDMA) induced neurotoxicity was studied. |
|
|